Maverick AI vs Nym
Two Autonomous Medical Coding vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Maverick AI | Nym | |
|---|---|---|
| Pricing model | Not published · custom, tied to coding volume | Per-transaction / per-chart · Priced per successfully coded chart |
| Speed to go live | customers typically live within 90 days | 3-6 months, FHIR-based EHR integration |
| Automation model | Autonomous agents · direct-to-bill autonomous coding | Autonomous agents · Fully autonomous coding, zero human review |
| Built for | Mid-size groups, Enterprise systems, Billing companies | Mid-size groups, Enterprise systems |
| Security posture | HIPAA | SOC 2 Type II, HIPAA |
| Company maturity | 7 yrs (est. 2019) | 8 yrs (est. 2018) |
| Financial backing | $11.5M (per PitchBook) · Seed plus strategic investment | $94.5M · Growth equity |
| Named customers | 1 named | 2 named |
| Published results | Specific numbers public | No public numbers |
| Documented integrations | 1 listed | 5 listed |
| Third-party validation | None found | None found |
Bottom line
- Pick Maverick AI if you want charts coded and sent to billing without human coders, with 85 percent direct-to-bill.
- Pick Nym if you have high-volume ED, radiology, or outpatient coding and can fund a months-long integration to take humans out of the loop entirely.
Maverick AI
Real-time autonomous medical coding for revenue cycle teams
- Founded
- 2019
- HQ
- n/a
- Stage
- Seed plus strategic investment
- Raised
- $11.5M (per PitchBook)
What it does
- Real-time autonomous coding via the mCoder platform
- 85%+ direct-to-bill rate without human touch
- Codes most cases in seconds
- Reported 95% coding accuracy
- Streams coded results straight to billing systems
Where it's strong
- Real-time coding with a published 85%+ direct-to-bill rate, ahead of the batch processing common in the category.
- Proven at national scale through the RadNet implementation across US imaging sites.
- The Infinx investment and partnership give it a distribution channel into established RCM operations.
What buyers should weigh
- Widely cited reports of a $47M 2025 raise belong to competitor Nym, not Maverick; Maverick's disclosed funding is about $11.5M, so weigh vendor financial durability.
- Public proof points are concentrated in radiology; ask for evidence in other specialties.
- Roughly 15% of cases still route to human coders, so plan for a review workflow.
Named customers
RadNet
Integrations
Nym
Explainable autonomous coding for ED and outpatient
- Founded
- 2018
- HQ
- New York, NY
- Stage
- Growth equity
- Raised
- $94.5M
What it does
- Fully autonomous coding with zero human touch
- Assigns ICD-10 and CPT codes in seconds per chart
- Explainable audit trail justifying every code
- Covers emergency medicine, radiology, outpatient surgery, urgent care
- Processes over six million charts annually
Where it's strong
- True zero-touch autonomous coding, with codes assigned in seconds and no human in the loop for in-scope charts.
- Explainability is the differentiator: every code comes with a traceable justification, which audit and compliance teams value.
- Deployed in 40+ US hospitals including Geisinger and Ochsner, processing over six million charts a year.
What buyers should weigh
- Supports six service lines (ED, radiology, outpatient surgery, outpatient visits, inpatient professional, urgent care); everything else still needs coders.
- Charts falling outside the engine's confidence threshold route back to your human coding staff, so plan for a hybrid operation.
- A new CEO (Lori Jones) arrived in April 2026, so watch for strategy and roadmap shifts.
Named customers
Geisinger · Ochsner Health
Integrations
Compare against the rest of Autonomous Medical Coding
Deciding between these two?
First Pass tracks Autonomous Medical Coding every week: funding, launches, and what changed since this page was written.